The prognostic value of [(18)F]FDG PET/CT based response monitoring in metastatic melanoma patients undergoing immunotherapy: comparison of different metabolic criteria

PURPOSE: To investigate the prognostic value of [(18)F]FDG PET/CT as part of response monitoring in metastatic melanoma patients treated with immune checkpoint inhibitors (ICIs). METHODS: Sixty-seven patients underwent [(18)F]FDG PET/CT before start of treatment (baseline PET/CT), after two cycles (...

Descripción completa

Detalles Bibliográficos
Autores principales: Sachpekidis, Christos, Weru, Vivienn, Kopp-Schneider, Annette, Hassel, Jessica C., Dimitrakopoulou-Strauss, Antonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317882/
https://www.ncbi.nlm.nih.gov/pubmed/37099131
http://dx.doi.org/10.1007/s00259-023-06243-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317882/
https://www.ncbi.nlm.nih.gov/pubmed/37099131
http://dx.doi.org/10.1007/s00259-023-06243-y

Ejemplares similares